BEGIN:VCALENDAR VERSION:2.0 PRODID:-//IBSAL - ECPv6.18.3//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:IBSAL X-ORIGINAL-URL:https://ibsal.es/en/ X-WR-CALDESC:Events for IBSAL REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD TZOFFSETFROM:+0000 TZOFFSETTO:+0000 TZNAME:UTC DTSTART:20240101T000000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Helsinki BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20251026T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20260329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20261025T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20270328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20271031T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20280326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20281029T010000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20250326 DTEND;VALUE=DATE:20300604 DTSTAMP:20251114T074015Z CREATED:20250304T093623Z LAST-MODIFIED:20251114T074015Z UID:10002030-1742947200-1906761599@ibsal.es SUMMARY:Diverse and responsible health DESCRIPTION:The project “Diverse and Responsible Health” aims at the scientific dissemination of the IBSAL among the LGTBI+ population of Salamanca. Through a series of workshops scheduled throughout 2025\, various key issues for the health of this group will be addressed\, promoting a gender and diversity perspective in medical and scientific research. \nThese workshops\, led by the Eros Service of Asociación Iguales\, will have the participation of specialized professionals\, IBSAL research staff and collaborating entities. The program includes four sessions with the following topics: \n\n\n\n\nITS: Why do they always point the finger at us? – Analysis of sexually transmitted infections in the LGTBI+ population and the need for a person-centered approach.\n\n  \nDate: Wednesday\, March 26\, 2025\, at 7:00 p.m. \nPlace: La Vegatería (C/ Gütenberg\, 13\, 37007 Salamanca) \nIBSAL Researchers: Moncef Belhassen and Virginia Velasco \nFree admission \n  \n \n  \n\nChemSex: an emerging phenomenon or an old acquaintance? – Study of ChemSex and its impact on health from a community perspective.\n\n  \nMore information coming soon. \n  \n\nLifestyles in queer people – Promotion of healthy habits and analysis of health determinants in the LGTBI+ population.\n\n  \nMore information coming soon. \n  \n\nMental health: how to take better care of ourselves – Minority stress\, discrimination and other barriers that affect the mental health of minorities.\n\n  \nMore information coming soon. \n  \nEach workshop will combine the presentation of specialists in the field with the participation of IBSAL research staff\, bringing scientific research closer to the community. \nThe project has the collaboration of several local entities and is supported by the University of Salamanca\, the City Council of Salamanca and the IBSAL. URL:https://ibsal.es/en/evento/diverse-and-responsible-health/ LOCATION:La Vegatería\, 13 Gütenberg Street\, Salamanca\, Salamanca\, 37007\, Spain CATEGORIES:Disclosure ATTACH;FMTTYPE=image/png:https://ibsal.es/wp-content/uploads/2025/03/Logo-Iguales-Tagline-Color.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20280102 DTSTAMP:20251124T061504Z CREATED:20251124T061504Z LAST-MODIFIED:20251124T061504Z UID:10002268-1767225600-1830383999@ibsal.es SUMMARY:PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR) DESCRIPTION:Features\nThe first joint transnational call for proposals from the EUP OHAMR Partnership on Antimicrobial Resistance\, titled “Treatments and Adherence to Treatment Protocols” \nThe goal of this call for proposals is to improve treatment success rates in patients\, animals\, and plants affected by bacterial or fungal infections by offering new treatment options while reducing the risk of resistance development across the various settings of the “One Health” approach . \nThe call for proposals is co-financed by the European Union and involves 37 funding organizations from 28 countries\, with a total estimated budget of more than 31 million euros. \nIn addition\, the following national and regional funding agencies are participating in this call for proposals: the Aragon Institute of Health Sciences (IACS)\, the State Research Agency (AEI)\, and the Carlos III Health Institute (ISCIII). \nRequirements\nProposals must address one of the following topics: \nTopic 1: Identify and develop new combination therapies using existing or innovative antimicrobials\, or antimicrobials in combination with adjunctive therapies\, to extend drug efficacy and combat resistance. \nTopic 2: Develop tools and methods to improve adherence to treatment protocols. \nTopic 3: Assess the impact of antimicrobials used in veterinary and agricultural settings on the risk of AMR transmission to humans and the environment\, to inform policies on restricting certain antimicrobials for human use. \n\nSubmission deadline.\nThe following table lists the different dates: \n\n\n\nPhase\nDate\n\n\n\n\nCall Opens\nNovember 18\, 2025\n\n\nDeadline for Pre-Proposals\nFebruary 2\, 2026\, (1:00 p.m. CET)\n\n\nNotification of the Results of the Pre-Proposal\nApril 29\, 2026\n\n\nDeadline for full proposals\nJune 17\, 2026\, (1:00 p.m. CET)\n\n\nFinal Funding Recommendation Announced\nOctober 30\, 2026\n\n\nProjects begin\nDecember 2026–April 2027\n\n\n\n  \n  URL:https://ibsal.es/en/evento/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20280102 DTSTAMP:20251124T120728Z CREATED:20251124T120728Z LAST-MODIFIED:20251124T120728Z UID:10002252-1767225600-1830383999@ibsal.es SUMMARY:ERA4HEALTH Partnership DESCRIPTION:Features\nThe ERA4HEALTH partnership has published a joint transnational call \, “Prevent-OO: Understanding and Preventing Overweight and Obesity” Mechanisms of their onset and progression\, neglected determinants\, and novel strategies for critical transitional periods in life. \nThe call for proposals seeks to identify and implement innovative and holistic preventive and public health strategies to address obesity\, taking into account environmental\, psychological\, and socioeconomic factors to promote healthier lifestyles. In addition\, ERA4Health fosters transnational and interdisciplinary collaborations with a translational approach to generate new knowledge and develop effective prevention strategies. \nThe call for proposals is co-financed by the European Union and involves 25 funding organizations from 20 countries\, with a total estimated budget of more than 18 million euros. \nIn addition\, the Carlos III Health Institute (ISCIII) is participating in this call for proposals as the national funding agency. \nRequirements\nApplications must cover only one of the two topics listed below and address at least one of the two specified subtopics (subtopic 1a and/or 1b for topic 1\, and subtopic 2a and/or 2b for topic 2); both topics and subtopics are equally relevant for this call: \n1. Understanding the causes of obesity and overweight and their complications through mechanistic research \n1a. To investigate biological mechanisms—including chronobiological\, genetic\, and/or epigenetic mechanisms—underlying the onset and progression of overweight and obesity\, as well as related diseases. Secondary factors that may influence these biological mechanisms—such as the living environment\, lifestyle\, or psychological status—should also be considered where relevant. \n1b. To investigate how being overweight and obesity contribute to the development of related clinical complications and/or affect the mechanism of action of treatments for other diseases or disorders. \n2. Prevention and public health strategies for critical transitional periods of life. Both subtopics 2a. and 2b. should address critical transitional periods of life only. The choice of the critical transitional periods of life to be studied must be clearly justified in the proposal. These periods should result from biological changes (e.g.\, postpartum\, menopause\, andropause) or socio-environmental changes (e.g.\, the period between pregnancies\, diagnosis of a chronic disease\, recovery from illness\, retirement\, etc.). \n2a. To understand and address neglected determinants—including their interdependence—in the onset and progression of overweight and obesity during transitional periods of life. \n2b. To develop novel tools or preventive strategies that can be implemented to prevent the onset and progression of overweight and obesity during transitional periods of life\, taking into account physiological\, pathophysiological\, psychological\, and behavioral influences and/or the socioeconomic status of citizens/patients. Importantly\, the proposal should include an assessment of the economic impact of the proposed tools or strategies on the healthcare system and provide recommendations to help policymakers define new regulations and guidelines to prevent overweight and obesity. \n\nSubmission deadline.\nThe following table lists the different dates: \n\n\n\nPhase\nDate\n\n\n\n\nCall Opens\nNovember 13\, 2025\n\n\nDeadline for Pre-Proposals\nJanuary 21\, 2026\, (12:00 CET)\n\n\nNotification of the Results of the Pre-Proposal\nApril 13\, 2026\n\n\nDeadline for full proposals\nJune 11\, 2026\, (12:00 CET)\n\n\nRebuttal Phase\nAugust 24\, 2026\n\n\nProjects begin\nDecember 2026–May 2027\n\n\n\n  \n  URL:https://ibsal.es/en/evento/era4health-partnership-2/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20280102 DTSTAMP:20251126T071112Z CREATED:20251126T071112Z LAST-MODIFIED:20251126T071112Z UID:10002178-1767225600-1830383999@ibsal.es SUMMARY:PARTNERSHIP European Partnership for Personalized Medicine (EP PerMed) DESCRIPTION:Features\nA joint transnational call for proposals has been published by the European Partnership for Personalized Medicine (EP PerMed)\, Joint Transnational Call (JTC) 2026: Personalized Medicine for Cardiovascular\, Metabolic\, and Kidney Diseases (CARMEN2026) \nThis call for proposals will fund human health research projects on innovative personalized medicine strategies for patients with cardiovascular\, metabolic\, or kidney diseases. Research projects may focus on a single disease or address these conditions in combination. \nResearch projects that combine a personalized medicine approach with care strategies targeting shared biological pathways or common underlying mechanisms of cardiovascular\, metabolic\, and renal diseases will be viewed favorably. \nThe call for proposals is co-funded by the European Union and involves 39 funding organizations from 27 countries\, with a total estimated budget of over 38 million euros. \nIn addition\, the Carlos III Health Institute (ISCIII) is participating in this call for proposals as the national funding agency. \nRequirements\nProposals should address one or more of the following aspects: \n\nDevelopment and validation of innovative\, personalized therapeutic approaches for cardiovascular\, metabolic\, or kidney diseases through testing in relevant preclinical models (e.g.\, human cell cultures\, organoids\, organs-on-chips\, disease-specific animal models\, or in silico models).\nIdentification and validation of molecular markers/signatures or cutting-edge technologies (see also point 2 below) to monitor treatment response in patients with cardiovascular\, metabolic\, or kidney diseases in order to tailor treatment pathways. This may include the analysis of treatment effectiveness or treatment-related (including those associated with multiple medications) adverse effects\, as well as dose optimization. \nIdentification and validation of stratifying molecular markers or signatures\, or stratifying diagnostic technologies\, for the early prediction of disease risk and the prevention of disease progression or comorbidities in patients with cardiovascular\, metabolic\, or kidney diseases\, thereby delaying the progression to cardiovascular-kidney-metabolic syndrome.\n\n  \nResearch projects that combine a personalized medicine approach with care strategies targeting shared biological pathways or common underlying mechanisms of cardiovascular\, metabolic\, and kidney diseases are welcome. \nProjects funded under this call are also required to include a dedicated work package focusing on the translation or implementation of research outcomes into clinical practice\, with an emphasis on\, for example\, patient outcomes\, patient preferences\, costs\, reimbursement\, education (for healthcare providers\, patients\, and citizens)\, ELSA (ethical\, legal\, and societal aspects)\, or accessibility at the point of care. \nSubmission deadline.\nThe following table lists the different dates: \n\n\n\nPhase\nDate\n\n\n\n\nCall Opens\nNovember 25\, 2025\n\n\nDeadline for Pre-Proposals\nFebruary 10\, 2026\, (2:00 p.m. CET)\n\n\nNotification of the Results of the Pre-Proposal\nMay 5\, 2026\n\n\nDeadline for full proposals\nJune 9\, 2026\, (2:00 p.m. CET)\n\n\nRebuttal stage\nMid- to late August 2026\n\n\nNotification of Funding Decisions\nOctober 2026\n\n\n\n  \n  URL:https://ibsal.es/en/evento/partnership-european-partnership-for-personalized-medicine-ep-permed/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20280102 DTSTAMP:20251215T081017Z CREATED:20251215T081017Z LAST-MODIFIED:20251215T081017Z UID:10002206-1767225600-1830383999@ibsal.es SUMMARY:PARTNERSHIP: Transforming Health and Care Systems (THCS) DESCRIPTION:Features\nA joint transnational call for proposals has been published by the Transforming Health and Care Systems (THCS) partnership\, Joint Transnational Call for Proposals (2026) on Access to Care. \nThis call for proposals promotes the coordination and optimization of research and innovation efforts to support the necessary transformation of health and social care systems in Europe and partner countries. Its goal is to fund projects that help ensure equitable access to and appropriate use of health and care services\, providing policymakers and decision-makers with the knowledge and tools needed to reallocate resources effectively. \nThe projects\, based on existing evidence\, will develop innovative solutions to reduce inequalities in access to care by addressing financial models\, service delivery models\, and integrated and interdisciplinary care programs at all levels of the system. \nThe call for proposals is co-financed by the European Union and involves 32 funding organizations\, with a total estimated budget of more than 35 million euros. \nIn addition\, the Carlos III Health Institute (ISCIII) is participating in this call for proposals as the national funding agency. \nRequirements\nThe aim of the call is to fund research and innovation projects that\, within an ecosystem approach\, contribute to ensuring equitable access to and use of health and care services. Through the funded research and innovation projects\, policymakers and decision-makers should gain the knowledge and tools necessary to implement the reallocation of resources as the health and care system undergoes a transition to address new and ongoing challenges. \nAll proposals would benefit from co-creation with stakeholders\, particularly people from disadvantaged groups. Proposals are encouraged to incorporate elements of the social sciences as part of an interdisciplinary approach. \nThis call requires collaborative\, transnational research\, innovation\, and evaluation activities. It is mandatory to engage in one or more of the following types of activities: applied research\, implementation research\, piloting\, upscaling\, and/or testing. All projects must demonstrate proof of concept(s)\, validate concepts\, models\, or solutions\, and showcase demonstrations of solutions in relevant health and care ecosystems. The adaptation of already adopted solutions to other settings is also within the scope of this call. \n  \nSubmission deadline.\nThe following table lists the different dates: \n\n\n\nPhase\nDate\n\n\n\n\nCall Opens\nNovember 21\, 2025\n\n\nDeadline for Pre-Proposals\nFebruary 2\, 2026\, (2:00 p.m. CET)\n\n\nCall for Full Proposals\nStarting May 11\, 2026\n\n\nDeadline for full proposals\nJune 30\, 2026\, (2:00 p.m. CET)\n\n\nRebuttal stage\nSeptember 2026\n\n\nNotification of Funding Decisions\nLate October 2026\n\n\n\n  \n  URL:https://ibsal.es/en/evento/partnership-transforming-health-and-care-systems-thcs/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20270101 DTSTAMP:20260112T060813Z CREATED:20260112T060813Z LAST-MODIFIED:20260112T060813Z UID:10002251-1767225600-1798761599@ibsal.es SUMMARY:Reticular Model of Organization and Community Care for People with Mental Illness DESCRIPTION:Coeducational Course: “Reticular Model of Organization and Community Care for People with Mental Illness“ \n  \nObjective: \nTo explain how the network-based model for organizing mental health services and facilities works\, with a focus on the coordination of social and health care services and between mental health and primary care. \n  \nSpecific objectives: \n\nBecome familiar with all the health and social care services integrated into the mental health social-health care network under the network model. Describe the operations and objectives of the Assertive Community Treatment Unit. Conduct a study to develop a feasible proposal for implementation in your workplace.\nTo understand the changes introduced by the model to improve the quality of care in the field of mental health. \nIdentify the epistemological and organizational foundations of the model and its implementation in a healthcare region such as Zamora. \nTo lay the groundwork for coordination among distinct care networks—such as social-health\, social\, and health care networks—as well as to define the new roles of workers within these networks.\n\nDate: \nFrom August 1 to December 31\, 2025. \n  \nLocation: \nOnline and the Zamora Mental Health Department. \n  \nEnrollment: \n  \nRegistration is open throughout the academic year on an individual basis via our website. \nIn order to successfully complete the course and receive the relevant certificate\, it is necessary to complete 80% of the total program. \n  \nPrice: \n50 euros (USAL students\, PhD students\, IBSAL members\, students from developing countries\, primarily in Latin America). \n150 euros (general admission). \n  \nMethod of selection: \nEnrollment in the course will be carried out in strict order of enrollment (in courses with high demand\, preference will be given to IBSAL personnel)\, according to the agreement of the IBSAL Training Commission. \n  URL:https://ibsal.es/en/evento/reticular-model-of-organization-and-community-care-for-people-with-mental-illness/ LOCATION:Online\, Online CATEGORIES:Course END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260421 DTEND;VALUE=DATE:20270116 DTSTAMP:20260518T124654Z CREATED:20260518T124654Z LAST-MODIFIED:20260518T124654Z UID:10002294-1776729600-1800057599@ibsal.es SUMMARY:Call for Applications: INVESMIR SEC-CNIC Training Program 2026 DESCRIPTION:Purpose\nThe INVESMIR SEC-CNIC Program aims to supplement the training of medical professionals during their hospital residency by facilitating the development of a research project in the CNIC laboratories under the supervision of a CNIC scientist. \nThis program also aims to establish the necessary connections and partnerships so that\, upon completing their specialization\, these professionals can continue to develop their research projects at their respective hospitals\, with the support of the SEC and the CNIC. \n  \nTerms and Conditions\nA maximum of 10 spots will be awarded for the INVESMIR SEC-CNIC training program in the 2026 call for applications. \nThe potential recipient groups for the CNIC under this program and information regarding their research areas are available at the following link:\nhttps://www.cnic.es/es/investigacion/laboratorios \nInterested individuals must contact the research groups and be accepted into one of them in order to apply.\nIn all cases\, the training stints will be full-time. \nParticipants from hospitals outside the Community of Madrid will have their travel expenses to Madrid covered up to a maximum of 300 € (one round-trip from their usual place of residence; if traveling by public transportation\, it must be in economy class\, in accordance with the CNIC’s travel policy). In addition\, these participants will be reimbursed for accommodation expenses in Madrid up to a maximum of 250 euros per week. Any amounts exceeding the weekly limit will be offset against one another\, provided they do not exceed 1\,000.00 € over a four-week period. \nAll expenses must be supported by documentation\, including invoices issued in the participant’s name and proof of payments made from their bank account. The documentation must be sent in a single email to programa_formación@cnic.es within 10 calendar days after the end of the stay at the Center. Once the documentation has been reviewed\, the participant will be notified of which supporting documents must be submitted as original hard copies (invoices\, receipts\, or other supporting documents) and mailed to the Center’s address. \nParticipation in the internship will not entail any type of contractual relationship between the intern and the CNIC. \n  \nDuration and Length of Stay\nThe duration of the stay will be flexible\, ranging from 4 to 6 months\, in accordance with the regulations set forth in the MIR Training Program of the participant’s home hospital.\nStays must take place entirely between June 1\, 2026\, and May 31\, 2027\, except in exceptional circumstances duly authorized by the CNIC and SEC management. \n  \nRequirements\nBe a member of the Spanish Society of Cardiology (SEC).\nBe a medical professional\, of any nationality\, currently in the R3\, R4\, or R5 years of a residency program in Cardiology or Cardiovascular Surgery at a hospital in Spain. \n  \nDeadline and Formalization\nThe call for applications will be open from April 21\, 2026\, through January 15\, 2027.\nApplications must be submitted exclusively through the CNIC online system:\nhttps://www.cnic.es/es/convocatoria/invesmir-sec-cnic\, and the following documentation must be attached: \n\nResume.\nNational Identity Card.\nDocument verifying your personal Social Security number (those issued by mutual insurance companies are not valid).\nA signed authorization from the Academic Committee of the training program at the participant’s home hospital\, expressly stating the dates of the stay.\nLetter of Acceptance from the CNIC Supervising Researcher Responsible for the Stay\nBrief description of the proposed research project for the residency\nCertificate of residence for candidates residing in Spain outside the Community of Madrid.\n\nDocuments must be attached to the form in PDF format. \nFollowing the publication of the call for applications\, applications will be reviewed on the 15th of each month. Each applicant will then be notified by email whether their application has been accepted or\, if applicable\, the reasons for requiring corrections or for exclusion. Applicants in the correction phase may correct the errors that led to the rejection of their application within a maximum period of 5 days\, starting the day after the notification date. The decision regarding admission to or exclusion from the evaluation process will be communicated through the same procedure. \nElectronic signatures will be used throughout the selection process and the subsequent hiring procedures; therefore\, applicants must have a digital ID (DNIe) or a recognized electronic certificate issued by a registered certification authority (https://sedeaplicaciones.minetur.gob.es/Prestadores/)\, such as the one issued by the National Mint and Stamp Factory. \nTERMS AND CONDITIONS OF THE CALL FOR APPLICATIONS URL:https://ibsal.es/en/evento/call-for-applications-invesmir-sec-cnic-training-program-2026/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260501 DTEND;VALUE=DATE:20270101 DTSTAMP:20260518T094535Z CREATED:20260518T094535Z LAST-MODIFIED:20260518T094535Z UID:10002280-1777593600-1798761599@ibsal.es SUMMARY:EATRIS-CONNECCT Knowledge Exchange Program DESCRIPTION:Features\nThe call for applications for the EATRIS-CONNECT knowledge exchange program offers grants of up to €1\,000 for researchers who wish to spend time at an eligible research institution\, with a focus on improving digital transformation in translational medicine. The program covers travel\, lodging\, and living expenses related to the visit. \nDigital transformation in translational medicine refers to the use of advanced digital technologies—such as data\, tools\, and services—to develop innovative solutions to unmet medical needs. \nThe call for applications is open to both EATRIS-CONNECT project partners and EATRIS organizations that are not officially part of the consortium. Expenses will be reimbursed upon completion of the visit and submission of the final report. \nRequirements\nWhat types of exchanges are funded? \nThere are no predefined exchange types\, but some examples include: \n\nDigital Transformation Literacy (DT Literacy): Individual staff exchanges between nodes to facilitate the transfer of knowledge related to digital solutions\, workflows\, and service delivery that support the development of translational medicine.\nWorkshops: group exchange of best practices or collaborative development of digital solutions.\nCollaborative initiatives: sharing experiences and ideas to drive joint digital transformation initiatives.\nOnline or virtual knowledge-sharing sessions: digital seminars\, webinars\, and other virtual events for sharing knowledge.\n\n\n\n\nHow to apply\nYou must submit the “Knowledge Exchange proposal” via this link to the application form. Before submitting it\, please verify your eligibility\, and we recommend that you read the program guide. \nThere is no deadline for submitting applications. URL:https://ibsal.es/en/evento/eatris-connecct-knowledge-exchange-program/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260716 DTEND;VALUE=DATE:20261116 DTSTAMP:20260717T081311Z CREATED:20260717T081311Z LAST-MODIFIED:20260717T081311Z UID:10002266-1784160000-1794787199@ibsal.es SUMMARY:“Salamanca Institute of Biomedical Research – Royal Academy of Medicine” Award DESCRIPTION:Description\nThe “Salamanca Biomedical Research Institute – Royal Academy of Medicine” Award for the best innovative work in health sciences conducted in 2026 by medical and non-medical professionals affiliated with the Salamanca Biomedical Research Institute (IBSAL). \n\n\n\n  \nAward\nThe prize consists of €1\,000 and a certificate. \n  \nPresentation\nTo submit an entry\, the candidate for the award must send the work and the relevant documentation (CVN and 3 copies of the work\, along with an electronic copy. In the case of multiple authors\, informed consent from all authors must be provided for the submission of the work to the award) for evaluation\, along with detailed information on the project’s current status. \nThe documents should be sent to the Academy’s email address\, ramsa@usal.es. \nThe documentation must be submitted by 1:00 p.m. on November 15\, 2026. \n  \nEvaluation\nThe judging panel\, composed of four Full Members of the RAMSA\, will issue its final evaluation based on the following criteria: the originality of the innovation—which may be basic\, clinical\, educational\, managerial\, etc.; its impact; other aspects that the committee deems relevant regarding the merits demonstrated by the author\, provided that they are related to the innovation. \n  \nRead the rules URL:https://ibsal.es/en/evento/salamanca-institute-of-biomedical-research-royal-academy-of-medicine-award/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260803 DTEND;VALUE=DATE:20261106 DTSTAMP:20260903T093329Z CREATED:20260903T090320Z LAST-MODIFIED:20260903T093329Z UID:10002378-1785715200-1793923199@ibsal.es SUMMARY:BREAKTHROUGH T1D\, Type 1 Diabetes Research DESCRIPTION:Features\n  \nThe Breakthrough T1D organization is now accepting applications for project concepts. This is a semi-annual call for Letters of Intent for Strategic Research Agreements that address Breakthrough T1D’s current research strategy. \nThis call supports individual and collaborative projects that address critical gaps and challenges in type 1 diabetes research. \nRequirements:\n\nProposals may be submitted by nonprofit or public organizations. Generally\, for-profit organizations will not be considered\, except under special circumstances. \nApplicants must hold an MD\, DMD\, DVM\, DO\, PhD\, or equivalent degree and hold a faculty position or equivalent at a college\, university\, medical school\, company\, or other research facility.\n\nHow to apply\nThe application process consists of two steps. Letters of Intent (LOIs) must be submitted through the RMS360 portal. Letters of Intent and full proposals are due by 5:00 p.m. Eastern Time on the following deadline dates: \nRound 1: \nLetters of Intent due November 5\, 2026 (link) \nNotification by December 17\, 2026 \nRound 2: \nLetters of Intent are due on May 6\, 2027 \nNotification by URL:https://ibsal.es/en/evento/breakthrough-t1d-type-1-diabetes-research/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260901 DTEND;VALUE=DATE:20261103 DTSTAMP:20260903T110132Z CREATED:20260903T110132Z LAST-MODIFIED:20260903T110132Z UID:10002386-1788220800-1793663999@ibsal.es SUMMARY:EASD Albert Renold Travel Fellowship Program DESCRIPTION:Features\nThe EASD Albert Renold Travel Fellowships enable scientists and clinicians to travel and stay at other institutions in order to learn specific techniques or clinical skills required for the advancement of their diabetes research project and not available at their home institution. \nThe home institution and/or the host institution must be based in Europe or a country associated with Europe (for a detailed list of countries\, please see here); both must be nonprofit organizations\, and each must be located in a different country. Applicants must be employed at their home institution during the term of the award. \nThe duration of the stay may be up to 3 months. The requested amount for each fellowship may be up to 10\,000 euros. \nRequirements:\n\nApplicants must be early-career scientists or clinicians who\, as of January 1 of the year the fellowship is awarded\, have completed their most recent degree (PhD\, MSc\, or MD) within the past 7 years. Eligibility may be extended for duly justified career breaks. Fellows may not hold a permanent appointment. \nThe home and/or host institution must be based in Europe or a country associated with Europe; both must be nonprofit organizations\, and each must be located in a different country. Applicants must be employed at their home institution during the duration of the grant. \nSuccessful applicants must travel within nine months of receiving the award.\nFunds cannot be used to help pay for part of a longer stay.\nAwardees may not receive a second fellowship within two years of receiving their award.\nApplicants must be members of the EASD in good standing.\n\nHow to apply\nApplications must be submitted through the EFSD portal by 12:00 p.m. (CET) on the deadline\, November 2\, 2026. URL:https://ibsal.es/en/evento/easd-albert-renold-travel-fellowship-program-2/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260901 DTEND;VALUE=DATE:20261117 DTSTAMP:20260903T112956Z CREATED:20260903T112956Z LAST-MODIFIED:20260903T112956Z UID:10002387-1788220800-1794873599@ibsal.es SUMMARY:German Academic Exchange Service (DAAD) Binationally Supervised Doctoral Degrees / Cotutelle DESCRIPTION:Features\nThe Deutscher Akademischer Austauschdienst (DAAD) / German Academic Exchange Service offers the“Bi-nationally Supervised Doctoral Degrees / Cotutelle” program. This program provides doctoral candidates with the opportunity to pursue a bi-national doctoral degree at their home university and at a university in Germany. \nThere are two types of doctoral programs: \n\nOption a) Doctorate with binational supervision (“sandwich model”): The PhD project is supervised jointly by an academic advisor at the home university and another at the host institution in Germany. The doctoral degree is awarded by the home university. \nOption b) Joint Doctoral Program: The PhD project is carried out jointly at the home university and a university in Germany under an individual joint supervision agreement established specifically for the project. Upon successful completion\, the two universities jointly award the doctoral degree. \n\n  \nThe scholarship provides €1\,400 per month for the research stay in Germany\, for a period of 7 to 24 months. \nIt also includes a travel allowance\, a €460 research allowance\, and health\, accident\, and liability insurance. Additional allowances may be available depending on the applicant’s circumstances. \nRequirements:\n\nAs a general rule\, the most recent university degree must have been earned no more than 6 years prior to the application deadline.\nIf the doctoral program has already begun\, it must have started no more than 3 years before the application deadline.\nApplicants must not have been residents of Germany for more than 15 months as of the application deadline.\nFor the “Sandwich Model\,” applicants must hold a master’s degree or a Diplom (or\, in exceptional cases\, a bachelor’s degree) by the start of the funding period.\nFor the “Cotutelle model\,” applicants must have been admitted to a doctoral program by the start of the funding period.\n\n\nHow to apply\nApplications must be submitted online via the DAAD Portal—by clicking the “SUBMIT AN APPLICATION” button. Applicants must complete the online application form and upload the required supporting documents\, including the research proposal\, CV\, motivation letter\, academic documents\, and the confirmation from the German supervisor. \nFor the Cotutelle option\, an individual Cotutelle agreement between the home university and the German university is required before the funding period begins. The application deadline is November 16\, 2026. URL:https://ibsal.es/en/evento/german-academic-exchange-service-daad-binationally-supervised-doctoral-degrees-cotutelle-2/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260907 DTEND;VALUE=DATE:20261107 DTSTAMP:20260903T084350Z CREATED:20260903T082838Z LAST-MODIFIED:20260903T084350Z UID:10002376-1788739200-1794009599@ibsal.es SUMMARY:Sarcoma Foundation of America (SFA) Research Grants DESCRIPTION:Features\nThe Sarcoma Foundation of America Research Grants support researchers conducting preclinical\, translational\, and clinical research on the etiology\, molecular biology\, pathogenesis\, diagnosis\, and treatment of human sarcomas. This program supports research and promotes awareness and advocacy for sarcoma patients and their families. The goal of the SFA grant program is to support research that leads to improved treatment options for sarcoma patients. The SFA encourages applications from ALL areas of sarcoma research. \nThe total award amount is $75\,000 for one year. The grants are awarded on an annual basis from July 1\, 2027\, to June 30\, 2028. SFA encourages applications in ALL areas of sarcoma research from U.S. and international applicants. \nRequirements:\n\nApplicants must hold an MD\, DO\, PhD\, or international equivalent—whether in the U.S. or abroad—and possess the skills\, knowledge\, and resources necessary to carry out the proposed sarcoma research;\nOnly one applicant may be designated as the principal investigator (PI) for each grant. The PI is responsible for the overall management\, coordination\, and oversight of the research\, including all deliverables; \nApplications from researchers outside the U.S. must be able to provide a budget and accept funds in U.S. dollars;\nReturning SFA principal investigators and organizational grantees must comply with all previous SFA grant deliverables\n\nHow to apply\nThe SFA Research Grant Program is a two-stage process. All applicants must submit a Letter of Intent (LOI). Only the highest-ranked LOIs will be invited to submit full applications. \nThe deadline for submitting the Letter of Intent is November 6\, 2026\, at 11:59 p.m. EST. The link to Proposal Central for Applicants & Awardees. URL:https://ibsal.es/en/evento/sarcoma-foundation-of-america-sfa-research-grants/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260909 DTEND;VALUE=DATE:20261117 DTSTAMP:20260909T115154Z CREATED:20260909T115154Z LAST-MODIFIED:20260909T115154Z UID:10002380-1788912000-1794873599@ibsal.es SUMMARY:DKMS John Hansen Research Grant 2026 DESCRIPTION:Features\nThe DKMS John Hansen Research Grant provides funding for research into hematopoietic stem cell transplantation and cell therapy for hematological diseases. The application period for the 2027 grant is now open. \nThe DKMS John Hansen Research Grant supports promising young scientists conducting research in the field of blood cancer\, with a particular focus on hematopoietic stem cell transplantation and cell therapy for hematological diseases. Projects primarily focused on product development\, commercialization\, or other commercial activities are not eligible. \nThe grant may cover\, among other things\, consumables\, the principal investigator’s (PI) own position\, a Ph.D. student dedicated to the project\, technicians who devote at least 30% of their time to the project\, relevant training\, and certain publication costs. Up to EUR 2\,500 per year can be used for travel\, lodging\, and registration fees for a scientific conference to present project results\, and up to EUR 10\,000 may be allocated for reasonable publication costs\, including open-access fees. \nThe grant lasts up to 3 years. Each annual funding period runs from July 1 to June 30 of the following year. The funding amounts to up to EUR 240\,000\, with a maximum of EUR 80\,000 per year. \nRequirements:\n\nApplicants from all countries are welcome to apply.\nApplicants must have earned a doctoral degree (PhD\, MD\, or equivalent) in a field relevant to the grant within the 10 years preceding the start of the call for proposals.\nApplicants must appoint a supervisor\, ideally a senior scientist at the host institution with expertise relevant to the proposed research.\n\nHow to apply\nApplicants must submit: \n\ninformation about the applicant;\na description of the research project; and\na budget plan\, following the application instructions.\n\nApplications must be submitted via email to grant@dkms.org by November 16\, 2026\, at 11:59 p.m. (Central European Time). URL:https://ibsal.es/en/evento/dkms-john-hansen-research-grant-2026/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20260917T000000 DTEND;TZID=Europe/Helsinki:20261118T140000 DTSTAMP:20261008T174018Z CREATED:20261008T174018Z LAST-MODIFIED:20261008T174018Z UID:10002443-1789603200-1795010400@ibsal.es SUMMARY:2027 Health Research Call for Proposals - La Caixa Foundation DESCRIPTION:Call for Proposals Summary\nThe “la Caixa” Foundation will fund biomedical and health research projects with the aim of identifying and promoting promising initiatives that demonstrate scientific excellence and have potential value and social impact\, in basic\, clinical\, and translational research alike. \nSubmitted projects must fall within the following thematic areas: \n\nNeuroscience.\nOncology.\nCardiovascular and related metabolic diseases.\nInfectious diseases.\nEnabling technologies in the four thematic areas mentioned above; proposals focused on the creation and development of health-enabling technologies from the following fields:\n\nMicro- and nanoelectronics.\nComputer science\, big data\, and artificial intelligence.\nPhotonics.\nNanotechnology and biotechnology.\nAdvanced materials or advanced manufacturing.\n\n\n\n  \nAmount\nProject proposals must have an implementation period of up to 3 years and may be: \n\nIndividual grants: submitted by a single research organization (applicant organization). They may receive funding of up to €500\,000. \nResearch consortia: submitted by a minimum of 2 and a maximum of 5 research organizations\, coordinated by the applicant organization. They may receive grants of up to 1\,000\,000 €. \n\n  \nRequirements\nRequirements for applicants: \nRequesting institution:\n\n\nProjects led by researchers from nonprofit research organizations located in Spain or Portugal are eligible to apply . \nThere will be two types of grants awarded: \n\nIndividual proposals: submitted by a single research organization (applicant organization).\nResearch consortia: submitted by a minimum of two and a maximum of five research organizations\, coordinated by the applicant organization.\n\n  \nResearch organizations: \nAny nonprofit organization located in any country in the world that carries out activities related to the project. In research consortia\, there must be a minimum of 2 and a maximum of 5 research organizations. \n  \nCivil society organizations: \nIn addition\, both individual projects and research consortia may also include up to three nonprofit civil society organizations whose primary activity is not research. \n  \nCompanies: \nEstablished companies cannot be members of the project\, but they can receive funding as subcontractors. \nOverall\, organizations not based in Spain or Portugal may not receive more than 30% of the total project budget. \n\nPI requirements:\n\nThe project must have a Project Leader (PL)\, who will be the principal investigator at the applicant organization. The Project Leader is responsible for submitting the proposal in response to the call for proposals and for overseeing the overall implementation of the project. \nIn addition\, for projects submitted by consortia\, each research organization must have a principal investigator responsible for carrying out the project activities conducted at that organization. \n  \n Project Leader (PL) Requirements: \n\nThe project must be led by researchers of any nationality who are affiliated with nonprofit research institutions located in Spain or Portugal.\nThe Project Leader must be the Principal Investigator at the applicant organization\, who submits the proposal in response to the call for proposals and oversees the overall implementation of the project.\nThe Project Leader must have at least seven years of postdoctoral experience ( as of the application deadline).\nProject leaders of projects funded in the three previous rounds of this call for proposals may not serve as project leaders for new proposals in this round. \nA single researcher may not serve as the project leader on more than one application in this call for proposals; however\, that researcher may participate as a principal investigator or collaborator on multiple applications.\nWith the aim of improving the quality of proposals\, Principal Investigators (PIs) and Project Leaders (PLs) of projects that received a score below 5.50 ( out of a maximum of 8) in the peer review of the previous call (CaixaResearch Health Call 2026) may not serve as PLs on proposals for this call (CaixaResearch Health Call 2027).\nSimilarly\, the Principal Investigators (PIs) and Principal Investigators (PIs) of projects that receive a score below 6.00 (out of a maximum score of 8) in the peer review for this edition (CaixaResearch Health Call 2027) will not be eligible to submit proposals as PIs in the next edition (CaixaResearch Health Call 2028). Furthermore\, the Principal Investigator (PI) and the Project Leader (PL) of proposals rejected during the content eligibility review for the current call will not be eligible to submit proposals as Principal Investigators in the next call. \n\n\nRequirements for Researchers\n\n\nTeam members. All members of the project team must be affiliated with the applicant organization\, civil society organizations\, or organizations in the research consortium.\n\n\n\n  \nApplications\nApplications must be submitted online through the La Caixa Foundation’s application portal. \n  \nMore information: https://caixaresearch.org/es/convocatoria-caixaresearch-investigacion-salud \nCOMPLETE RULES \n  \n  URL:https://ibsal.es/en/evento/2027-health-research-call-for-proposals-la-caixa-foundation/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260921 DTEND;VALUE=DATE:20261212 DTSTAMP:20261028T094445Z CREATED:20261028T091518Z LAST-MODIFIED:20261028T094445Z UID:10002459-1789948800-1797033599@ibsal.es SUMMARY:Integrated Services for Infectious Disease Outbreak Research\, ISIDORe—Andes Virus and ANDV-Related Hantavirus Research DESCRIPTION:Features\nThe call for proposals titled “Andes Virus & ANDV-relevant Hantavirus Research” is part of ISIDORe II\, an initiative funded by the European Union’s Horizon Europe program to facilitate access to specialized research infrastructure and services for infectious diseases. \nThe main feature is that it does not provide a financial grant to the researcher or their institution. Instead\, it funds access to specialized scientific services provided by the participating infrastructures\, at no cost to the selected users. \nProposals must address the Andes virus (ANDV) or research on hantaviruses that is clearly related to it. Research on other hantaviruses without justifying that relationship falls outside the scope of this call for proposals. \nThree priority areas are established: \n\nEvaluation of treatments and non-vaccine-based prophylaxis. Evaluation and characterization of antiviral candidates\, antibodies\, and other therapeutic or preventive strategies that already have a scientific basis. \nDiagnostics\, assays\, and reference materials. Development or adaptation of assays\, evaluation of sensitivity and specificity\, analytical validation\, reagents\, controls\, and reference materials. \nModels and experimental systems. Use and characterization of models to study pathogenesis\, viral tropism\, host response\, or the evaluation of medical countermeasures. \n\n  \nServices available: \n\n\n\n\nAnalysis: RT-PCR design\, NGS sequencing\, and whole-genome sequencing of ANDV. \n\n\n\n\n\n\nDrug discovery: screening of antiviral compounds\, validation of candidates\, and characterization of monoclonal antibodies. \n\n\n\n\n\n\nCell-based and ex vivo models: human organoids\, lung\, placenta\, and endothelial models\, and antiviral assays. \n\n\n\n\n\n\nIn vivo models: preclinical efficacy studies and animal models\, subject to applicable scientific and ethical requirements. \n\n\n\n\n\n\nImmunomonitoring and structural biology: cellular immunity assays\, protein production and characterization\, and advanced microscopy techniques. \n\n\n\n\n\n\nRegulatory and clinical support: guidance on preparing research studies and addressing ethical or regulatory issues. \n\n\n\n\nThe availability of a service in the general catalog does not guarantee that any use of that service is eligible: it must comply with the priorities and exclusions of this specific call for proposals. \n  \n  \nRequirements\nThe call for proposals is open to researchers from universities\, public research institutions\, public health organizations\, companies\, small and medium-sized enterprises\, and other organizations that conduct research. \nThe main requirements and conditions are: \n\n\n\n\nScientific scope: The proposal must address ANDV or an issue related to another hantavirus whose relevance to ANDV is clearly justified. \n\n\n\n\n\n\nAccess to services: You must request one or more services included in the ISIDORe II catalog. \n\n\n\n\n\n\nTransnational dimension: Horizon Europe’s transnational access (TNA) rules apply. The principal investigator and the majority of users must meet the geographic access conditions with respect to the hosting facility. The location of the service is determined during the process. \n\n\n\n\n\n\nPriority: Preference will be given to applicants who did not receive funding in the first ISIDORe project. \n\n\n\n\n\n\nEthics and security: Applicable requirements regarding ethics\, biosafety\, bioprotection\, data protection\, and the use of services must be met. \n\n\n\n\n\n\nDissemination: The results must be disseminated\, and ISIDORe’s contribution must be appropriately acknowledged. \n\n\n\n\nAt least 80% of access must benefit users from EU Member States or countries associated with Horizon Europe; up to 20% may be allocated to international users who meet the relevant conditions. \nThe call for proposals guidelines state that the following are not included: \n\n\n\n\nRoutine diagnosis and epidemiological surveillance. \n\n\n\n\n\n\nClinical trials. \n\n\n\n\n\n\nManufacturing and scaling of production processes. \n\n\n\n\n\n\nWide-ranging screening campaigns without a specific hypothesis or need. \n\n\n\n\n\n\nDevelopment of entirely new services that are not available in the current offering. \n\n\n\n\nWe are looking for a specific scientific need that can be addressed through specialized services available at the participating research infrastructures. \nHow to apply\nThe application consists of two phases: a preliminary application and a full application. It is important to review the full text of the call for proposals to verify scientific relevance and eligibility criteria. Applications are submitted through the application management system (Access Management System\, AMS). \nThis link takes you to the services catalog\, where you can view available infrastructure and services. URL:https://ibsal.es/en/evento/integrated-services-for-infectious-disease-outbreak-research-isidore-andes-virus-and-andv-related-hantavirus-research/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260921 DTEND;VALUE=DATE:20261231 DTSTAMP:20261002T082542Z CREATED:20261002T082542Z LAST-MODIFIED:20261002T082542Z UID:10002428-1789948800-1798675199@ibsal.es SUMMARY:Scientific and Technical Sessions for Senior Clinical and Biomedical Diagnostic Technicians DESCRIPTION:Scientific and Technical Sessions for Senior Clinical and Biomedical Diagnostic Technicians \n  \nObjective: \nTo update knowledge on diagnostic procedures\, quality control\, and new laboratory tools. \n  \nSpecific objectives: \nTo analyze the quality control procedures applied to hematopoietic progenitor cells in the context of allogeneic transplantation. \nTo determine the diagnostic utility and clinical application of the GFAP and UCH-L1 biomarkers in patients with mild acute brain injury. \nTo evaluate the utility of automated hematology systems and their correlation with conventional morphological methods. \n  \nDate: \nStart Date: September 21\, 2026 \nEnd: December 30\, 2026 \n  \nLocation: \nCAUSA DP0518 Auditorium \nProgram: \n\n\n\nDate / Time\nLocation\nSpeaker\nContent\n\n\nSeptember 21\, 26\nCAUSA DP0518 AUDITORIUM\n– María Magdalena Barbero García\n– CORRELATION BETWEEN HEMOGLOBIN LEVELS MEASURED BY THE GEM 5000 WERFEN BLOOD GAS ANALYZER AND THE SIEMENS ADVIA 2120I CYTOMETER\n\n\n13:30 / 15:30\n\n\n10/26/19\nCAUSA DP0518 AUDITORIUM\n– REBECA ORTEGA HERRERA\n– QUALITY CONTROL OF HEMATOPOIETIC PROGENITOR CELLS USING CLONOGENIC ASSAYS IN THE CONTEXT OF ALLOGENEIC TRANSPLANTATION. \nFUNCTIONAL COMPARISON OF FRESH VERSUS CRYOPRESERVED PROGENITOR CELLS\n\n\n13:30 / 15:30\n\n\n11/23/26\nCAUSA DP0518 AUDITORIUM\n– SOFIA GONZALEZ MARTIN\n– DETERMINATION OF BIOMARKERS FOR MILD ACUTE BRAIN INJURY IN THE EMERGENCY ROOM LABORATORY: GFAP AND UCH-L1\n\n\n13:30 / 15:30\n\n\n12/14/26\nCAUSA DP0518 AUDITORIUM\n– MARIA DE LOS ANGELES GOMEZ GONZALEZ\n– CORRELATION BETWEEN THE ADVIA 2120 AUTOMATED LEUKOCYTE DIFFERENTIAL COUNT AND THE MORPHOLOGICAL COUNT ASSISTED BY CELIAVISION\n\n\n13:30 / 15:30\n\n\n\nEnrollment: \nREGISTRATION: \nIndividually\, through our website. \nIn order to successfully complete the course and receive the relevant certificate\, it is necessary to complete 80% of the total program. \nSeats: \n30 for IBSAL staff \nMethod of selection: \nEnrollment in the course will be carried out in strict order of enrollment (in courses with high demand\, preference will be given to IBSAL personnel)\, according to the agreement of the IBSAL Training Commission. \n  URL:https://ibsal.es/en/evento/scientific-and-technical-sessions-for-senior-clinical-and-biomedical-diagnostic-technicians/ LOCATION:Hospital Clínico. Complejo Asistencial Universitario de Salamanca (Salamanca University Welfare Complex)\, Pº de San Vicente\, 182\, Salamanca\, Salamanca\, Spain CATEGORIES:Sacyl Course END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260921 DTEND;VALUE=DATE:20261231 DTSTAMP:20261005T104413Z CREATED:20261005T104413Z LAST-MODIFIED:20261005T104413Z UID:10002432-1789948800-1798675199@ibsal.es SUMMARY:Scientific and Technical Sessions for Senior Clinical and Biomedical Diagnostic Technicians DESCRIPTION:  \nScientific and Technical Sessions for Senior Clinical and Biomedical Diagnostic Technicians \n  \nObjective: \nTo update knowledge on diagnostic procedures\, quality control\, and new laboratory tools. \n  \nSpecific objectives: \nTo analyze the quality control procedures applied to hematopoietic progenitor cells in the context of allogeneic transplantation. \nTo determine the diagnostic utility and clinical application of the GFAP and UCH&8209;L1 biomarkers in patients with mild acute brain injury. \nTo evaluate the utility of automated hematology systems and their correlation with conventional morphological methods. \n  \nDate: \nStart Date: September 21\, 2026 \nEnd: December 30\, 2026 \n  \nLocation: \nCAUSA DP0518 Auditorium \nProgram: \n\n\n\nDate / Time\nLocation\nSpeaker\nContent\n\n\nSeptember 21\, 26\nCAUSA DP0518 AUDITORIUM\n– María Magdalena Barbero García\n– CORRELATION BETWEEN HEMOGLOBIN LEVELS MEASURED BY THE GEM 5000 WERFEN BLOOD GAS ANALYZER AND THE SIEMENS ADVIA 2120I CYTOMETER\n\n\n13:30 / 15:30\n\n\n10/26/19\nCAUSA DP0518 AUDITORIUM\n– REBECA ORTEGA HERRERA\n– QUALITY CONTROL OF HEMATOPOIETIC PROGENITOR CELLS USING CLONOGENIC ASSAYS IN THE CONTEXT OF ALLOGENEIC TRANSPLANTATION. \nFUNCTIONAL COMPARISON OF FRESH VERSUS CRYOPRESERVED PROGENITOR CELLS\n\n\n13:30 / 15:30\n\n\n11/23/26\nCAUSA DP0518 AUDITORIUM\n– SOFIA GONZALEZ MARTIN\n– DETERMINATION OF BIOMARKERS FOR MILD ACUTE BRAIN INJURY IN THE EMERGENCY ROOM LABORATORY: GFAP AND UCH-L1\n\n\n13:30 / 15:30\n\n\n12/14/26\nCAUSA DP0518 AUDITORIUM\n– MARIA DE LOS ANGELES GOMEZ GONZALEZ\n– CORRELATION BETWEEN THE ADVIA 2120 AUTOMATED LEUKOCYTE DIFFERENTIAL COUNT AND THE MORPHOLOGICAL COUNT ASSISTED BY CELIAVISION\n\n\n13:30 / 15:30\n\n\n\nEnrollment: \nREGISTRATION: \nIndividually\, through our website. \nIn order to successfully complete the course and receive the relevant certificate\, it is necessary to complete 80% of the total program. \nSeats: \n30 for IBSAL staff \nMethod of selection: \nEnrollment in the course will be carried out in strict order of enrollment (in courses with high demand\, preference will be given to IBSAL personnel)\, according to the agreement of the IBSAL Training Commission. \n  URL:https://ibsal.es/en/evento/scientific-and-technical-sessions-for-senior-clinical-and-biomedical-diagnostic-technicians-3/ LOCATION:Salamanca CATEGORIES:Sacyl Course END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20260924T081500 DTEND;TZID=UTC:20261210T094500 DTSTAMP:20260901T110351Z CREATED:20260831T120427Z LAST-MODIFIED:20260901T110351Z UID:10002361-1790237700-1796895900@ibsal.es SUMMARY:2nd Edition of the Continuing Education Program on Inflammatory Nasal and Sinus Diseases in Castile and León DESCRIPTION:“Second Edition of the Continuing Education Program on Inflammatory Nasal and Sinus Diseases in Castile and León” \n  \nObjective: \n\n\n\nTo determine therapeutic management and experience in treating patients with severe chronic non-polypoid sinusitis (CNPS). \nTo establish criteria for the indication and treatment of various nasosinusal conditions (epistaxis\, septopyramidal deviation\, eosinophilic otitis).\n\n\n\n  \nSpecific objectives: \n  \n\n\n\n-Establish a treatment strategy\, incorporating biologics into the current treatment algorithm. \n-Evaluation of real-world outcomes of treatment with biologic drugs. \n-Establish a standardized approach to the management of epistaxis in the emergency department. \n-Establish the criteria for surgical indication and the surgical techniques for patients with septopyramidal deviation.\n\n\n\n  \nLocation: \nTEAMS link. \n  \nProgram: \n\n\n\nCourse Date\nSchedule\nContent\nSPEAKER \n\n\n Thursday\, September 24\, 2026\n8.15-9.45\n  \n‘s Septorhinoplasty Online \n \nMs. María Gil Melcón \nHead of the Otolaryngology Section. CAUSA \n\n\n Thursday\, November 5\, 26\n8.15-9.45\n  \nEosinophilic Otitis: Diagnosis\, Treatment\, and Outcomes in CAUSA \nOnline \n \nMs. Susana Marcos Alonso \nL.E.A. Otolaryngology. CAUSE \n\n\n Thursday\, December 10\, 2026\n8.15-9.45\nDupilumab in Real-World Practice in CAUSA \nOnline.\nMr. Juan Carlos del Pozo de Dios \nL.E.A. Otolaryngology. CAUSE. \n\n\n\n  \nEnrollment: \nREGISTRATION: \nThe registration deadline is Tuesday\, September 22\, 2026; you must register individually through our website. \nIn order to successfully complete the course and receive the relevant certificate\, it is necessary to complete 80% of the total program. \n  \nMethod of selection: \nEnrollment in the course will be carried out in strict order of enrollment (in courses with high demand\, preference will be given to IBSAL personnel)\, according to the agreement of the IBSAL Training Commission. \n  URL:https://ibsal.es/en/evento/2nd-edition-of-the-continuing-education-program-on-inflammatory-nasal-and-sinus-diseases_castile-and-leon/ LOCATION:Salamanca CATEGORIES:Course ATTACH;FMTTYPE=image/png:https://ibsal.es/wp-content/uploads/2026/08/Regeneron-logo--scaled.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20261001T081500 DTEND;TZID=UTC:20261127T094500 DTSTAMP:20260902T075759Z CREATED:20260901T105743Z LAST-MODIFIED:20260902T075759Z UID:10002363-1790842500-1795772700@ibsal.es SUMMARY:2nd Edition of the Continuing Education Program on Inflammatory Nasal and Sinus Pathology in Salamanca DESCRIPTION:“2nd Edition of the Continuing Education Program on Inflammatory Nasal and Sinus Diseases in Salamanca” \n  \nObjective: \n\n\n\nTo determine therapeutic management and experience in treating patients with severe chronic non-polypoid sinusitis (CNPS). \nTo establish criteria for the indication and treatment of various nasosinusal conditions (epistaxis\, septopyramidal deviation\, eosinophilic otitis). \n \n\n\n\n  \nSpecific objectives: \n  \n\n\n\n-Establish a treatment strategy\, incorporating biologics into the current treatment algorithm. \n-Evaluation of real-world outcomes of treatment with biologic drugs. \n-Establish a standardized approach to the management of epistaxis in the emergency department. \n-Establish the criteria for surgical indication and the surgical techniques for patients with septopyramidal deviation. \n \n\n\n\n  \nDate: October 1\, 2026\, through November 26\, 2026 \n  \nLocation: \nLibrary of the Otolaryngology Department at the University Hospital of Salamanca. \n  \nProgram: \n\n\n\nCourse Date\nSchedule\nContent\nSpeaker\n\n\nThursday\, \n\, October 1\, 26\n8.15-9.45\nMultiple-choice case studies of patients with cPN-CSC treated with biologic drugs. \nIn-person\nMs. Susana Marcos Alonso \nL.E.A. Otolaryngology. CAUSE \n\n\nThursday\, \n\, October 22\, 2026\n8.15-9.45\nEpistaxis: Therapeutic Management. \nIn-person\nMs. María Gil Mencón \nHead of the Otolaryngology Section. CAUSA \n\n\nThursday\, November 26\, \n\n8.15-9.45\nComprehensive Treatment of cPN-CSR: Surgery and Biologics. \nIn-Person\nMr. Fernando Franco Calvo \nHead of the Otolaryngology Department. CAUSA \n\n\n\nEnrollment: \nREGISTRATION: \nThe registration deadline is Friday\, September 29\, 2026; please register individually through our website. \nIn order to successfully complete the course and receive the relevant certificate\, it is necessary to complete 80% of the total program. \n  \n  \nMethod of selection: \nEnrollment in the course will be carried out in strict order of enrollment (in courses with high demand\, preference will be given to IBSAL personnel)\, according to the agreement of the IBSAL Training Commission. \n  URL:https://ibsal.es/en/evento/2nd-edition-of-the-continuing-education-program-on-inflammatory-nasal-and-sinus-diseases-salamanca/ LOCATION:Salamanca CATEGORIES:Course ATTACH;FMTTYPE=image/png:https://ibsal.es/wp-content/uploads/2026/08/Regeneron-logo--scaled.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20261005 DTEND;VALUE=DATE:20261107 DTSTAMP:20260917T123727Z CREATED:20260917T120713Z LAST-MODIFIED:20260917T123727Z UID:10002409-1791158400-1794009599@ibsal.es SUMMARY:An Overview of the Donation and Transplant Process DESCRIPTION:Online course: \nAn Overview of the Donation and Transplant Process. \nObjective: \nTo raise awareness and improve healthcare workers’ knowledge of the donation and transplantation process. \nSpecific objectives: \nImproving the identification of potential donors at the facilities of the Salamanca Healthcare Complex \nDissemination of the Maastricht III protocol and procedure for donation in cases of asystole. \nUpdates on the care and support of potential donors. Improving healthcare staff’s skills in interacting with the donor’s family. \nDATE: \nOctober 5 through November 6\, 2026 \nLocation: \nIBSAL Moodle Platform \nProgram: \nMonday\, October 5\, 2026 \n\n4:00 p.m. – 4:20 p.m. | Course Introduction (M.A. Bravo)\n4:30 p.m. – 5:00 p.m. | The Donation Process: Medical Records (V. Sagredo)\n5:00 p.m. – 5:30 p.m. | Donation Process: Nursing Perspective (M.A. Bravo)\n5:30 p.m. – 6:00 p.m. | Brain Death: Clinical Aspects (M. Gutiérrez)\n6:00 p.m. – 6:30 p.m. | Brain Death: Instrumental Diagnosis (S. Muñoz)\n\nTuesday\, October 6\, 2026 \n\n4:00 p.m. – 4:30 p.m. | Clinical evaluation of the donor (M. Bueno)\n4:30 p.m. – 5:00 p.m. | Donor Care (I. Fernández)\n5:00 p.m. – 5:30 p.m. | Nursing Care for Donors (J.C. Martín)\n5:30 p.m. – 6:10 p.m. | Maastricht III Asystole Donor (Á. García)\n\nWednesday\, October 14\, 2026 \n\n3:55 p.m. – 4:00 p.m. | Module II Presentation (M.A. Bravo)\n4:00 p.m. – 6:00 p.m. | Legal Issues and Clinical Documentation (M.D. Calvo)\n6:00 p.m. – 8:00 p.m. | Family and Donation (Fr. Rojo)\n\nWednesday\, October 21\, 2026 \n\n3:55 p.m. – 4:00 p.m. | Presentation: Module III (M.A. Bravo)\n4:00 p.m. – 4:30 p.m. | Maastricht III Donation After Cardiac Death (M.A. Bravo)\n4:30 p.m. – 5:00 p.m. | Transplant Immunology (A. Tejeda)\n5:00 p.m. – 6:00 p.m. | Liver Removal and Transplantation (C. Esteban\, M.J. Iglesias)\n6:00 p.m. – 6:30 p.m. | Pancreas Transplant (J. López)\n6:30 p.m. – 7:00 p.m. | Kidney Retrieval and Transplantation Techniques (Ó. Heredero\, J. Salvatierra)\n7:00 p.m. – 7:30 p.m. | Kidney Transplantation from a Living Donor (P. Eguiluz\, A. Martín)\n7:30 p.m. – 8:00 p.m. | Robotic and Complex Kidney Transplants (A. Palacios\, C. Sánchez)\n\nTuesday\, October 27\, 2026 \n\n3:55 p.m. – 4:00 p.m. | Presentation: Module IV (M.A. Bravo)\n4:00 p.m. – 4:30 p.m. | The Eyeball and Corneal Implants (G. Rodríguez)\n4:30 p.m. – 5:00 p.m. | Osteotendinous tissue (S. Serrano)\n5:00 p.m. – 5:30 p.m. | Bone Marrow Transplant (L. López)\n5:30 p.m. – 6:00 p.m. | Follow-up Care for Kidney Transplant Patients (G. Tabernero)\n6:00 p.m. – 6:30 p.m. | Postoperative Care for Pancreas and Kidney Surgery (M. González)\n6:30 p.m. – 7:30 p.m. | Roundtable Discussion: Patient Organizations and Patient Experiences (M.A. Bravo\, A. Rivero)\n7:30 p.m. – 8:00 p.m. | The Present and Future of Organ Donation and Transplantation (M.A. Bravo\, V. Sagredo)\n\n  \nSeats: \n5 for IBSAL staff \nEnrollment: \nREGISTRATION: \nNote: HUS staff who are not affiliated with IBSAL must register through the GESTION@FC training application: www.salud.jcyl.es/gestio@fc \nThe pre-registration period for IBSAL staff runs through Friday\, October 1\, via our website. \nIn order to successfully complete the course and receive the relevant certificate\, it is necessary to complete 80% of the total program. \nPlease note that you can only be considered registered for the course when you receive the confirmation email\, as there is a limit to the number of places available. \nSELECTION METHOD: \nEnrollment in the course will be carried out in strict order of enrollment (in courses with high demand\, preference will be given to IBSAL personnel)\, according to the agreement of the IBSAL Training Commission. \n  \n  \n  \nIBSAL TRAINING URL:https://ibsal.es/en/evento/an-overview-of-the-donation-and-transplant-process/ LOCATION:Salamanca CATEGORIES:Sacyl Course END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20261008 DTEND;VALUE=DATE:20261111 DTSTAMP:20260930T114159Z CREATED:20260921T083446Z LAST-MODIFIED:20260930T114159Z UID:10002417-1791417600-1794355199@ibsal.es SUMMARY:Mental Health in People with Intellectual Disabilities: Assessment and Intervention. DESCRIPTION:In-person/online course: \nMental Health in People with Intellectual Disabilities: Assessment and Intervention. \nObjective: \nIdentify and understand intervention methods for behavioral and/or psychiatric disorders in people with intellectual disabilities. \nSpecific objectives: \n\nAddressing Mental Health Issues (Primarily Behavioral and Psychiatric Disorders) Among People with Intellectual Disabilities: Current Situation and Needs.\n\n  \n\nIdentify and understand the main behavioral and psychiatric issues faced by people with intellectual disabilities.\n\n  \n\nLearn the assessment and diagnostic methodology for people with intellectual disabilities who have mental health issues.\n\n  \n\nTo understand intervention methodologies for people with intellectual disabilities who exhibit behavioral and psychiatric disorders\n\n  \n\nReview the principles of pharmacological treatment for people with intellectual disabilities and mental health issues. And establish the best strategies for pharmacological intervention. \n\n  \n\nTo learn about and evaluate the different models of care for people with intellectual disabilities and mental health issues\, with a particular focus on Castile and León\, as well as to learn about the resources available in Castile and León and how to access them.\n\n  \n\nTo evaluate the best intervention methodology for improving the care and treatment of psychiatric and behavioral problems in people with intellectual disabilities.\n\n  \n  \nDATE: \nOctober 8\, 2026\, and November 10\, 2026 \nLocation: \nZamora Healthcare Complex—Virgen de la Concha Hospital // Online \nProgram: \n\n\n\nDate of delivery\nSchedule\nContent\nTeacher and Qualification\n\n\n8/10/2026\n9:30-10:00\nCourse introduction and teaching methodology. Relevance of the topic. \nManuel A. Franco Martín. \nPsychiatrist. Chief of the Department of Psychiatry and Mental Health at CAZA (ID No.: 09278225w)\n\n\nOctober 8\, 2026\n10:00–11:00\nMental Health and the Use of Psychotropic Medications in People with Intellectual and Developmental Disabilities in Castile and León.\nCarla Redondo Jimeno. \nHealth psychologist. Head of Social and Health Care Coordination at Plena inclusión CyL. (ID No.: 12413417H) \n\n\n\n8/10/2026\n11:00-11:45\nCommunity Support Model for People with Intellectual Disabilities and Behavioral Disorders. The Zamora Network Model. And User Evaluations \nManuel A. Franco Martín. \nPsychiatrist. Chief of the Department of Psychiatry and Mental Health at CAZA (ID No.: 09278225w)\n\n\n8/10/2026\n11:45-12:30\nSacyl Regional Reference Unit for Severe Behavioral and Acute Psychiatric Disorders at Santa Isabel Hospital in León: Clinical Profiles of Admitted Patients; Therapeutic Intervention Strategies; Clinical Case: The Complexity Requiring a Multidisciplinary Intervention. \nFrancisco Rodriguez Fernández. Psychiatrist . ( ID No.: 27383161M) Leticia Trigal García ( ID No.: 71713782N) Ana Cabezas Anido. Nurse (ID No.: 71435489L) Raquel Alonso Gómez\, Clinical Psychologist (ID No.: 71441971S)\, Cristina del Cano González\, Social Worker (ID No.: 09813908S) \nRegional Reference Unit for Behavioral Disorders in Intellectual Disabilities. León Healthcare Complex. \n\n\n8/10/2026\n12:30-13:15\nDual Pathology Unit for People with Intellectual Disabilities and Severe Behavioral Disorders. A Care and Educational Model for People with Intellectual Disabilities \n  \nFrom Social Services. Objectives and Expected Outcomes. \nVirginia Yagüe Gete \nHealth psychologist specializing in intellectual disabilities. Fundación Hospitalarias Palencia. (ID No.: 7289090L) \n \n\n\nOctober 8\, 2026\n1:15–2:00 p.m.\nThe Comprehensive Assessment Process for People with Intellectual Disabilities and Concerning Behaviors (Part I)\nRamon Novell Alsina. \nPsychiatrist specializing in mental health for people with intellectual disabilities. Former head of the mental health network specializing in intellectual disabilities in Girona\, Government of Catalonia (ID: 46516827V)\n\n\nOctober 8\, 2026\n3:30–4:30 p.m.\nThe Comprehensive Assessment Process for Individuals with Intellectual Disabilities and Behaviors of Concern (Part II)\nRamon Novell Alsina. \nPsychiatrist specializing in mental health for people with intellectual disabilities. Former head of the mental health network specializing in intellectual disabilities in Girona\, Government of Catalonia (ID: 46516827V)\n\n\n8/10/2026\n16:30-17:00\nBehavioral Disorder or Mental Illness: Challenges in Diagnosis and Treatment. \nManuel A. Franco Martín. \nPsychiatrist. Chief of the Department of Psychiatry and Mental Health at CAZA (ID No.: 09278225w)\n\n\n8/10/2026\n17:00-17:45\nDiagnostic Systems for Mental Illness in People with Intellectual Disabilities\nFrancisco Rodriguez Fernández. Psychiatrist . Regional Reference Unit for Behavioral Disorders in Intellectual Disabilities. León Healthcare Complex. (ID No.: 27383161M)\n\n\nOctober 8\, 2026\n5:45–6:30 p.m.\nMajor Mental Illnesses and Specific Characteristics in People with Intellectual Disabilities. \nCase study to work on at home.\nManuel A. Franco Martín. \nPsychiatrist. Chief of the Psychiatry and Mental Health Service at CAZA (ID No.: 09278225w)\n\n\nNovember 10\, 2026\n9:30–11:00\nIntroduction to the Comprehensive Support Model\nRamon Novell Alsina. \nPsychiatrist specializing in mental health for people with intellectual disabilities. Former head of the mental health network specializing in intellectual disabilities in Girona\, Government of Catalonia (ID: 46516827V)\n\n\n10/11/2026\n11:00-12:00\nThe Role of Antipsychotics in Mental (and Behavioral) Disorders Associated with Intellectual Disabilities: Proper Use and Risks. \nManuel A. Franco Martín. \nPsychiatrist. Chief of the Department of Psychiatry and Mental Health at CAZA (ID No.: 09278225w)\n\n\n10/11/2026\n12:00-12:30\nLong-acting injectable antipsychotics. Role in intellectual disability \nJuan García Mellado \nCoordinator of the Psychiatric Inpatient Unit at the Zamora Healthcare Complex (ID No.: 11950521C)\n\n\n10/11/2026\n12:30-13:00\nBenzodiazepines and Mood-Regulating Psychotropic Medications in Intellectual Disabilities\nFrancisco Rodriguez Fernández. Psychiatrist . Regional Reference Unit for Medium-Term Care for Intellectual Disabilities. León Healthcare Complex. (ID No.: 27383161M)\n\n\n10/11/2026\n1:00–1:30 p.m.\nOther Psychotropic Medications and Biological Treatments for Intellectual Disabilities\nDiscussion among the psychiatrists teaching the course about their previous experiences. And case reviews. \n\n\n10/11/2026\n13:30-14:00\nSTOP/STAMP. Strategies for Rationalizing the Use of Psychotropic Medications in Individuals with Intellectual Disabilities. \nRamon Novell Alsina. \nPsychiatrist specializing in mental health for people with intellectual disabilities. Former head of the mental health network specializing in intellectual disabilities in Girona\, Government of Catalonia (ID No.: 46516827V)\n\n\n10/11/2026\n15:30-18:00\nThe Positive Behavioral Support Model as a Psychotherapeutic Tool. 150 min \n· Primary and secondary prevention and reactive strategies \n· Person-Centered Planning \n· Low-activation strategies \n· Managing Stress and “Burnout” Among Professionals \n \nAinara Gómez Blanco. \nPsychologist. Director of the Plena Inclusión Mental Health Program in La Rioja (PPISAM). She is a member of the La Rioja mental health network. Director of the regional team responsible for assessing and designing support services for people with mental health and behavioral issues. (ID No.: 72789900Y)\n\n\nNovember 10\, 2026\n6:00–6:30 p.m.\nChanging Beliefs and Attitudes Toward People with Complex Behaviors\nCarla Redondo Jimeno. \nHealth psychologist. Head of Social and Health Care Coordination at Plena inclusión CyL. (ID No.: 12413417H) \n \n\n\n\n  \nSeats: \n\n\n20 free in-person spots. Reserved exclusively for individuals affiliated with a nonprofit organization serving people with intellectual disabilities and IBSAL professionals who are not part of Sacyl. \n\n\nUnlimited spots for live streaming at a cost of 20 euros.\n\n\n  \nEnrollment: \nREGISTRATION: \nNote: HUS staff who are not affiliated with IBSAL must register through the GESTION@FC training application: www.salud.jcyl.es/gestio@fc \nThe pre-registration period for IBSAL staff runs through Friday\, October 1\, via our website. \nIn order to successfully complete the course and receive the relevant certificate\, it is necessary to complete 80% of the total program. \nPlease note that you can only be considered registered for the course when you receive the confirmation email\, as there is a limit to the number of places available. \nSELECTION METHOD: \nEnrollment in the course will be carried out in strict order of enrollment (in courses with high demand\, preference will be given to IBSAL personnel)\, according to the agreement of the IBSAL Training Commission. \n  \n  \n  \nIBSAL TRAINING URL:https://ibsal.es/en/evento/mental-health-in-people-with-intellectual-disabilities-assessment-and-intervention/ LOCATION:Salamanca CATEGORIES:Sacyl Course END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20261014 DTEND;VALUE=DATE:20261125 DTSTAMP:20261016T071608Z CREATED:20261016T070420Z LAST-MODIFIED:20261016T071608Z UID:10002451-1791936000-1795564799@ibsal.es SUMMARY:III Research Grant: MALENA GARRIDO - Spanish Scleroderma Association (A.E.E.) DESCRIPTION:Purpose\nThe purpose of this call for proposals is for the Spanish Scleroderma Association (A.E.E.) to award grants to high-quality research projects on scleroderma conducted under the supervision of a principal investigator (PI). \nThe research project must have a clear impact on the quality of life of patients with scleroderma\, and there must be a solid research foundation to support the hypothesis presented in the proposal. \nThe projects submitted must be carried out entirely in Spain. \n  \nRequirements\nAny IP applying for this call must: \n— Be affiliated with a public or private nonprofit organization in Spain that is qualified to conduct scientific research. \n— Have at least two research articles published or accepted for publication as an author or co-author in a peer-reviewed scientific journal at the time of application. Publications dated after the application deadline will not be accepted. \n  \nFeatures of the Grant\nThis grant amounts to 22\,000 euros gross and will be disbursed in two payments: 50% of the total amount upon award\, and the remaining 50% upon submission of a preliminary report on the work completed to date. \n— The award of this grant shall not preclude the recipient from receiving other public or private funding for the evaluated project. However\, the existence of another source of funding will result in a penalty under the scoring criteria. \n— Members of the Board of Directors or the Scientific Committee of the Spanish Scleroderma Association may not participate in this grant program as applicants or collaborators. \n— The researcher must notify the A.E.E. of any cause of incompatibility. \n  \nApplication Requirements and Content\n— Applicants may submit only one proposal for this call for proposals. If the same project is submitted by different researchers\, both applications will be rejected. \n— If the applicant is not selected\, he or she may resubmit an application in future calls for proposals\, provided that changes have been made to the submitted project or to the laboratory where the project will be carried out\, in accordance with the comments in the evaluation report. \nSubmitting incomplete documentation may result in the denial of the application. Each application must include the following documents: \nPHASE I. PRELIMINARY PROPOSAL\n— Scanned copy of both sides of the national ID card\, valid residence permit\, or passport.\n— Candidate’s Abbreviated Curriculum Vitae (CVA) (maximum 4 pages). Achievements and contributions must be clearly reflected\, particularly in publications (indicate position on the list of authors)\, research projects\, and patents.\n— Preliminary proposal (PDF format\, maximum 4 pages) including: background\, research hypothesis\, social impact (relevance of the proposal)\, and bibliography. \nPHASE II: COMPLETE PROPOSAL\nThe ideas preselected during the first evaluation phase will be notified and must submit a complete proposal that includes: \n— Scientific research report: statement of responsibility\, scientific abstract\, popular science summary of the project\, plan for disseminating scientific results to the public\, and collaboration with the A.E.E.\, background\, objectives\, methodology\, work plan\, timeline\, significance of the work and its scientific and social impact\, justification of the proposal’s innovative nature\, ethical implications\, references and scientific background\, structure of the recipient group\, and a reasoned justification of the various items for which the requested grant will be used. \nThe affidavit signed by the applicant\, included in the scientific report\, must indicate whether any other type of grant or prior funding from public or private sources has been obtained or requested in connection with the submitted proposal. If such information is clearly omitted during the selection\, award\, or monitoring process for the grant\, the A.E.E. reserves the right to reject the application or\, as the case may be\, revoke the grant award and request the return of any funds disbursed. \n— Budget: Justifying the various items for which the requested grant will be used. Expenses related to patents and intellectual property must be included in the budget.\n— Approval from the research center where the project will be carried out\, which includes: \n\nA reasoned report from the investigative committee or the school administration.\nLetter of acceptance from the center’s management. This letter must be signed by the center’s legal representative. All industrial and intellectual property rights that may arise from the funded “\n” projects will be distributed in accordance with the rules and agreements of the RESEARCH CENTER. \nSpecification of the percentage that the research center will apply to the project for administrative expenses.\n\n  \nSubmission and Deadlines\n— Applicants must submit all documentation in a single email to the following address: beca_mg@esclerodermia.com. \n— The subject line of the email must include the word “SCHOLARSHIP” followed by the IP’s two last names. \n— The deadline for submitting applications is November 30\, 2026\, at 12:00 a.m. (peninsular time). Applications submitted after this deadline will not be accepted. \n— The applicant is responsible for all the information contained in the submitted documentation and guarantees its accuracy. If the application is submitted correctly\, the user will receive a confirmation receipt. \n— If the submitted application is incomplete or does not meet the requirements of this call for applications\, it will be rejected\, and there will be no opportunity to correct any errors. \n  \nCOMPLETE RULES \n  URL:https://ibsal.es/en/evento/iii-research-grant-malena-garrido-spanish-scleroderma-association-a-e-e/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20261019T000000 DTEND;TZID=Europe/Helsinki:20261113T150000 DTSTAMP:20261023T095250Z CREATED:20260724T062722Z LAST-MODIFIED:20261023T095250Z UID:10002257-1792368000-1794582000@ibsal.es SUMMARY:FERO Cancer Calls for Proposals 2027 DESCRIPTION:Objective\nThe goal of these calls for proposals is to promote translational cancer research projects and support researchers at various stages of their scientific careers in order to accelerate advances that will transform the future of cancer. \n  \nHelp\n— FERO Cancer Fellowship for Young Researchers 2027\n— FERO Cancer Fellowship for Young Medical Researchers 2027\n— Dr. Josep Baselga FERO Cancer Scholarship 2027\n— FERO Pediatric Cancer Scholarship 2027\n— FERO Women’s Cancer Grant 2027\, for projects focused on cancers that affect women. (NEW) \n— FERO Lung Cancer Grant – The Ricky Rubio Foundation 2027\, a new call for proposals to accelerate lung cancer research. (NEW) \n  \nDeadlines\nThe call for applications is not yet open. The application period begins on October 19\, 2026; the closing date has not yet been set. An “info day” will be held to finalize the details. \n  \nInfo Day\nIn order to present the new features of this edition\, explain the changes made to the guidelines\, share the new schedule\, and answer any questions about the application process\, an Info Day will be held for researchers and institutions. \n\nDate: September 29\, 2026\nTime: 11:00 a.m.–12:00 p.m.\nFormat: Online\n\nThose interested can register via the following link to gain access to the session:\nhttps://forms.office.com/e/0JLwjfjHvg?origin=lprLink \nIf you have any questions\, please contact beca@ferocancer.org URL:https://ibsal.es/en/evento/fero-cancer-calls-for-proposals-2027/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20261020T000000 DTEND;TZID=Europe/Helsinki:20261112T140000 DTSTAMP:20261008T172743Z CREATED:20261008T172743Z LAST-MODIFIED:20261008T172743Z UID:10002441-1792454400-1794492000@ibsal.es SUMMARY:University Faculty Training Grants (FPU) 2026 DESCRIPTION:Overview\nThe purpose of the University Faculty Training Grants (FPU) is to train doctoral candidates by funding pre-doctoral contracts\, so that recipients can conduct the research necessary to submit a doctoral dissertation and\, at the same time\, acquire the university teaching skills required to join the higher education system. \nThe grants will fund the establishment of employment contracts—specifically\, pre-doctoral contracts—as well as research stays at R&D centers and tuition fees associated with doctoral programs. In addition\, funding will be provided for a postdoctoral orientation period following the award of the doctoral degree\, for a maximum of twelve months within a four-year period\, aimed at the professional development and specialization of research staff\, provided that the degree is awarded during the grant’s implementation period. \nThe application for participation is submitted by the organization\, which must include the names of the participants. Selection is based on a competitive process\, and the criteria for evaluating applications are as follows: \n1. Academic Record (0–75) \n2. Quality and scientific and technical track record of the team that will carry out the project (0–25) \n 2.1 Scientific and Technical Background of the Thesis Advisor (0–10) \n 2.2. Scientific\, technical\, and educational context of the group in which the intervention will take place (0–15) \n  \nObjectives\nHiring will be conducted under a pre-doctoral contract\, in accordance with current labor laws\, Royal Decree 103/2019 of March 1\, and the provisions of this call for applications\, on a full-time basis\, and may last up to four years from the date the successful candidates begin their positions. \nThe grants will cover the following items: a grant to finance the contracts\, a grant to cover the cost of severance pay upon contract termination\, and an additional grant to cover expenses related to stays at R&D centers and enrollment in doctoral programs. \n  \nAmount\n– The grant to help finance the contract will be 32\,500 euros per year. \n– The grant to cover the cost of severance pay upon termination of the contract will be 3\,350 euros\, intended to cover any costs that may be incurred for this purpose during the grant period. \n– The grant to cover expenses related to stays at R&D centers and tuition for doctoral programs will be 10\,000 euros for the entire duration of the grant. \n  \nDeadlines \n\nDeadline for participants (form submission): October 20\, 2026 – November 12\, 2026\, at 2:00 p.m. (Spanish peninsular time)\nDeadline for organizations (signing and submission of application): October 20\, 2026 – November 20\, 2026\, at 2:00 p.m. (Spanish mainland time)\n\n  \nMore information: https://www.aei.gob.es/convocatorias/buscador-convocatorias/ayudas-contratos-fpu-2026/convocatoria URL:https://ibsal.es/en/evento/university-faculty-training-grants-fpu-2026/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20261021 DTEND;VALUE=DATE:20270130 DTSTAMP:20261026T092118Z CREATED:20261026T090010Z LAST-MODIFIED:20261026T092118Z UID:10002453-1792540800-1801267199@ibsal.es SUMMARY:International Myeloma Society (IMS) and Paula and Rodger Riney Foundation Translational Research Award DESCRIPTION:Features\nFunding from the International Myeloma Society (IMS) and the Paula and Rodger Riney Foundation supports translational research projects on multiple myeloma and other plasma cell disorders. Their goal is to advance findings that can be translated into clinical practice\, thereby improving the prevention\, early detection\, diagnosis\, and treatment of these diseases. It is essential that the project have a clear translational focus and a result that is potentially applicable in clinical practice; basic research on myeloma alone is not sufficient. \nTranslational research projects are accepted in all areas of plasma cell disorders\, particularly multiple myeloma. The research areas considered include: \n\n\n\n\nDevelopment of biomarkers and methods for diagnosis or early detection. \n\n\n\n\n\n\nNew molecular and imaging techniques. \n\n\n\n\n\n\nDevelopment and evaluation of drugs or biological agents. \n\n\n\n\n\n\nIdentification of new therapeutic targets using human biological samples\, including those from clinical trials. \n\n\n\n\n\n\nPreclinical or clinical research with the potential to change the way myeloma is prevented\, diagnosed\, or treated. \n\n\n\n\nThe project must have an initial duration of 12 months\, although an extension for an additional year may be requested on an exceptional basis. Funding covers personnel expenses\, laboratory supplies\, services\, and travel. Inventory items are not permitted unless their necessity is specifically justified. Funding ranging from 175\,000 USD to 250\,000 USD per project. \nRequirements:\n\n\n\n\nPrincipal Investigator (PI) Profile: The PI must be a university professor (faculty member) or an established researcher with an MD and/or PhD. \n\n\n\n\n\n\nResearch experience: We are seeking a researcher with a proven track record. Researchers from other fields who wish to focus their research on myeloma are also encouraged to apply. \n\n\n\n\n\n\nIMS Membership: The principal investigator or one of the co-investigators must be a member of the International Myeloma Society. \n\n\n\n\n\n\nAcknowledgment Requirement: Publications and presentations resulting from this grant must acknowledge the IMS and the Paula and Rodger Riney Foundation as sources of funding. \n\n\n\n\n\n\nTranslational impact: The proposal must explain how its results can be translated into clinical practice. \n\n\n\n\nWomen and researchers from underrepresented groups are especially encouraged to submit applications \nHow to apply\nThe application must be completed in English. The following documentation is required: \n\nOfficial application form. It must be completed and approved by the institution. \nScientific report\, bibliographic references\, scientific CV (biosketch)\, budget\, and statement of eligibility and translation.\n\nApplications are submitted through the IMS Grant Management System \nThe call for applications for 2027 is now open\, and the deadline is January 29\, 2027\, at 11:59 p.m. (EST) (the deadline corresponds to 5:59 a.m. on January 30\, 2027\, Spanish peninsular time). URL:https://ibsal.es/en/evento/international-myeloma-society-ims-and-paula-and-rodger-riney-foundation-translational-research-award/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20261021 DTEND;VALUE=DATE:20270130 DTSTAMP:20261026T103746Z CREATED:20261026T101932Z LAST-MODIFIED:20261026T103746Z UID:10002457-1792540800-1801267199@ibsal.es SUMMARY:International Myeloma Society (IMS) Career Development Award 2027 DESCRIPTION:Features\nThe International Myeloma Society (IMS) Career Development Award 2027 aims to advance the academic careers of young researchers working in the field of plasma cell disorders by fostering collaboration among institutions and providing training in a research environment different from that of their home institution. \nFunding is provided for one-year fellowships of up to 75\,000 USD. The recipient receives a free one-year IMS membership. The host institution must be different from the home institution and provide a substantial change in the research environment. \nRequirements\nThe researcher must be working in the field of multiple myeloma and must also meet the requirements related to professional experience and mobility. \n\n\n\n\nDegree: MD (Medicine) or PhD (Doctorate). Candidates currently pursuing a doctoral degree focused on plasma cell disorders will also be considered. \n\n\n\n\n\n\nCareer stage: You should not yet be an independent researcher. \n\n\n\n\n\n\nFuture career path: You must intend to pursue a career in the field of plasma cell disorders. \n\n\n\n\n\n\nPrevious funding: Applicants must not have received funding from the U.S. NIH or its international equivalent. \n\n\n\n\n\n\nEmployment Relationship with the Host Institution: You cannot already have an employment contract with the laboratory that will host you. \n\n\n\n\n\n\nChange of institution: The research must be conducted at an institution other than the researcher’s home institution and involve a substantial change in the research environment. Changes between laboratories within the same institution or between laboratories located in the same metropolitan area are not permitted. \n\n\n\n\n\n\nIMS Membership: The principal investigator at the home institution or the host institution must be an IMS member. \n\n\n\n\n\n\nLimit per laboratory: Each host laboratory may submit a maximum of one application per cycle. \n\n\n\n\nWe especially encourage nominations of women and members of underrepresented minorities. \nHow to apply\nThe application must be completed in English. The following documentation is required: \n\nOfficial application form. It must be completed and approved by the institution. \nResearch proposal\, bibliographic references\, the candidate’s resume\, letters of support from the home institution and the host laboratory\, and a budget and justification.\n\nApplications are submitted through the IMS Grant Management System \nThe call for applications for 2027 is now open\, and the deadline is January 29\, 2027\, at 11:59 p.m. (EST) (the deadline corresponds to 5:59 a.m. on January 30\, 2027\, Spanish peninsular time). URL:https://ibsal.es/en/evento/international-myeloma-society-ims-career-development-award-2027/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20261103T000000 DTEND;TZID=Europe/Helsinki:20261124T140000 DTSTAMP:20261008T171526Z CREATED:20261008T171345Z LAST-MODIFIED:20261008T171526Z UID:10002439-1793664000-1795528800@ibsal.es SUMMARY:Knowledge Generation Projects and Initiatives for the Training of Pre-doctoral Research Personnel 2026 DESCRIPTION:Purpose\nThe purpose of this call for proposals is to fund research projects aimed at both fostering the generation and significant advancement of scientific knowledge and high-quality research\, and at finding solutions to societal challenges\, by promoting initiatives at both the national and bilateral international levels. \nIn addition\, funding may be provided for activities aimed at training pre-doctoral researchers through the completion of a doctoral dissertation related to the aforementioned research projects. \n  \nBeneficiaries\nUniversities\, public R&D&I centers\, technology centers\, and public and private nonprofit organizations involved in science\, technology\, research\, and innovation. \n  \nProject Characteristics\nThere are two types of projects: \n1) Research Non-Targeted: projects without a predefined thematic focus whose primary objective is the advancement of knowledge\, regardless of the time frame or scope of application. \n2) Research Focused: aimed at solving specific problems linked to the thematic priorities associated with society’s major challenges\, as outlined in Annex III of the call for proposals. \nProjects may be carried out individually\, with one or two principal investigators and a research team\, or in a coordinated\, with several subprojects\, each with one or two principal investigators and a research team. \nWithin each category\, there are two types of projects based on the profile of the lead partner: \n\na) Projects Type A: Principal Investigators with significant and innovative scientific and technical contributions and leadership capabilities.\nb) Projects Type B: Principal Investigators with a proven track record in research.\n\nType B includes the following types of projects\, depending on the modality: \nResearch Methodology Unoriented \n— Type I: Projects carried out within the framework of an international bilateral collaboration involving at least two different multinational research teams\, one consisting of one or more Spanish institutions and the other consisting of one or more foreign research institutions.\nThese applications may be submitted for all thematic areas listed in Annex II. \n– Applied Research Track \n— RTA Type\, exclusively in the form of Targeted Research projects\, proposed by the CSIC’s National Institute for Agricultural and Food Research and Technology (INIA) and the public agricultural or food R&D&I centers under the jurisdiction of the Autonomous Communities\, which are part of the INIA (CSIC)-CCAA \nThe duration of the projects and subprojects will generally be 3 or 4 years\, depending on what is justified by the nature of the activities described in the scientific and technical report. \n  \nCharacteristics of Programs for Pre-Doctoral Research Training\nGrants for the training of pre-doctoral research staff are intended to fund activities aimed at training new Ph.D. graduates through the completion of a doctoral dissertation associated with a research project funded under this call for proposals\, including funding for the costs of hiring pre-doctoral research staff\, stays at R&D centers\, and tuition fees associated with doctoral programs. Additionally\, within the framework of these grants\, funding may be provided for a postdoctoral orientation period (POP)\, once the doctoral degree has been obtained\, aimed at the professional development and specialization of these researchers\, provided that the degree is obtained during the implementation period of the initiative for the training of pre-doctoral researchers. \nThe actions will have a maximum duration of four years. \nThe process of evaluation and selection of the person to be hired shall be the responsibility of the beneficiary entity. The beneficiary organization must prepare a report describing the selection process and justifying the suitability of the selected candidate\, based on the criteria established in the call for applications. \n  \nKnowledge Generation Projects\nThe objectives are to contribute to the development of the national and international leadership capacity of research teams in public and private nonprofit entities involved in R&D&I\, by facilitating their mobility and promoting their participation and success in European and international programs and projects; to enable the adoption of an interdisciplinary and multidisciplinary approach involving research groups with a critical mass capable of generating synergies among different scientific and technical approaches and promoting significant advances in scientific knowledge. \nThe grants provided for in this call for proposals will be used to cover costs directly and unambiguously related to the development and implementation of the activities for which they have been awarded. Funding may be applied to direct and indirect costs\, with indirect costs set at a fixed percentage of 25% of the project’s direct expenses. \nThe grants may cover up to 100 percent of the marginal costs for which funding is requested. \n  \nActivities for the training of pre-doctoral research staff associated with the projects:\nThe goal is to train new generations of researchers who will acquire the necessary skills while working in top-tier research teams\, including the promotion of mobility through short-term stays at other national and international centers\, as well as scientific and technological infrastructures and facilities. \nThe grants will cover the following expenses: hiring costs\, severance pay upon contract termination\, and expenses related to placements at R&D centers and enrollment in doctoral programs. They may include a postdoctoral orientation period (POP) of up to 12 months\, to be completed after obtaining a doctoral degree within the project’s implementation period\, aimed at professional development and specialization. \n  \nApplication Deadline\nThere will be a single application period\, from November 3 to November 24\, 2026\, at 2:00 p.m. (Spanish peninsular time). \n  \nMore information: https://www.aei.gob.es/convocatorias/buscador-convocatorias/proyectos-generacion-conocimiento-actuaciones-formacion-7 URL:https://ibsal.es/en/evento/knowledge-generation-projects-and-initiatives-for-the-training-of-pre-doctoral-research-personnel-2026/ LOCATION:Salamanca CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20261105T084500 DTEND;TZID=Europe/Helsinki:20261106T170000 DTSTAMP:20261015T063220Z CREATED:20261015T063219Z LAST-MODIFIED:20261015T063220Z UID:10002447-1793868300-1793984400@ibsal.es SUMMARY:18th Symposium on the Biological Bases of Cancer and Therapeutic Innovation DESCRIPTION:On November 5 and 6\, 2026\, the 18th Symposium on the Biological Basis of Cancer and Therapeutic Innovation will be held\, a conference focused on advances in cancer treatment and new therapeutic strategies that contribute to the development of more personalized oncology. \nThe program will address the personalized cancer treatment from a global perspective\, combining roundtable discussions focused on the most common clinical entities with educational lectures on current topics. In addition\, significant time will be set aside for discussion and the exchange of knowledge among participants. \nThe symposium is aimed primarily at medical oncologists\, medical residents\, researchers in translational oncology teams\, and students in their final years of medical school and graduate programs. In addition\, its content offers an opportunity for continuing education and training for professionals in the pharmaceutical industry. \nThe initiative includes seeking sponsorship from the Spanish Society of Medical Oncology (SEOM)\, ASEICA\, ACLO\, and the ECO Foundation\, as well as the inclusion of the event in SEOM’s +MIR program\, which is aimed at residents and young attending physicians. \nYou can find all the information on the event website. URL:https://ibsal.es/en/evento/18th-symposium-on-the-biological-bases-of-cancer-and-therapeutic-innovation/ LOCATION:Dioscorides Building\, 7 Coimbra University Avenue\, Salamanca\, Salamanca\, 37007\, Spain CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://ibsal.es/wp-content/uploads/2026/10/HUpmjydXMAAd4lP.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20261107T091500 DTEND;TZID=Europe/Helsinki:20261107T130000 DTSTAMP:20261030T123546Z CREATED:20261030T123531Z LAST-MODIFIED:20261030T123546Z UID:10002463-1794042900-1794056400@ibsal.es SUMMARY:1st Walk for Lung Transplants DESCRIPTION:1st Walk for Lung Transplants\n\n\n\n\n\nDate:\nSaturday\, November 7\, 2026\n\n\nTime:\n9:15 a.m. (Puente Romano Track and Field Facilities)\n\n\nLocation:\nSalamanca (from the Roman Bridge to the El Tormes Shopping Center)\n\n\nPrice:\n€3\n\n\nRoute:\n3 km\n\n\n\n\n* Registration will be open until Friday\, November 6\, 2026\, at 8:00 p.m.\n* T-shirts can be picked up on the day of the race\, starting at 9:00 a.m. at the starting area. \n\nWebsite URL:https://ibsal.es/en/evento/1st-walk-for-lung-transplants/ LOCATION:Puente Romano Track and Field Facilities\, P.º del Progreso\, 1\, Salamanca\, Salamanca\, 37008\, Spain CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://ibsal.es/wp-content/uploads/2026/10/marchatransplante26.jpg END:VEVENT END:VCALENDAR